These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 794727)

  • 1. Narcotic antagonist treatment of the criminal justice patient-institutional vs outpatient-including a 24 hour detox naltrexone induction regimen with oral medication.
    Brahen L; Wiechert V; Capone T
    NIDA Res Monogr; 1976 Sep; (9):93-8. PubMed ID: 794727
    [No Abstract]   [Full Text] [Related]  

  • 2. Varying clinical contexts for administering naltrexone.
    Hurzeler M; Gerwirtz D; Kleber H
    NIDA Res Monogr; 1976 Sep; (9):48-66. PubMed ID: 794721
    [No Abstract]   [Full Text] [Related]  

  • 3. An analysis of naltrexone use--its efficacy, safety and potential.
    Landsberg R; Taintor Z; Plumb M; Amico L; Wicks N
    NIDA Res Monogr; 1976 Sep; (9):106-13. PubMed ID: 1004529
    [No Abstract]   [Full Text] [Related]  

  • 4. Clinical experience with naltrexone in a behavioral research study: an interim report.
    Greenstein R; O'Brien C; Mintz J; Woody G; Hanna N
    NIDA Res Monogr; 1976 Sep; (9):141-9. PubMed ID: 794715
    [No Abstract]   [Full Text] [Related]  

  • 5. Use of narcotic antagonists (naltrexone) in an addiction treatment program.
    Lewis D; Hersch R; Black R; Mayer J
    NIDA Res Monogr; 1976 Sep; (9):99-105. PubMed ID: 794728
    [No Abstract]   [Full Text] [Related]  

  • 6. Medication-assisted treatment research with criminal justice populations: challenges of implementation.
    Gordon MS; Kinlock TW; Miller PM
    Behav Sci Law; 2011; 29(6):829-45. PubMed ID: 22086665
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patient response to naltrexone: issues of acceptance, treatment effects, and frequency of administration.
    Curran S; Savage C
    NIDA Res Monogr; 1976 Sep; (9):67-9. PubMed ID: 794722
    [No Abstract]   [Full Text] [Related]  

  • 8. Experiences with Naltrexone in Buffalo.
    Taintor Z; Landsberg R; Wicks N
    Am J Drug Alcohol Abuse; 1975; 2(3-4):391-401. PubMed ID: 775969
    [No Abstract]   [Full Text] [Related]  

  • 9. Clinical evaluation of naltrexone treatment of opiate-dependent individuals. Report of the National Research Council Committee on Clinical Evaluation of Narcotic Antagonists.
    Arch Gen Psychiatry; 1978 Mar; 35(3):335-40. PubMed ID: 365122
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comments and findings from a naltrexone double blind study.
    Keegan J; Lavenduski C; Schooff K
    NIDA Res Monogr; 1976 Sep; (9):74-6. PubMed ID: 794724
    [No Abstract]   [Full Text] [Related]  

  • 11. NIDA's naltrexone research program.
    Julius D
    NIDA Res Monogr; 1976 Sep; (9):5-11. PubMed ID: 187943
    [No Abstract]   [Full Text] [Related]  

  • 12. Philosophy and status of NAS CENA study.
    Hollister LE
    NIDA Res Monogr; 1976 Sep; (9):45-7. PubMed ID: 794720
    [No Abstract]   [Full Text] [Related]  

  • 13. Clinical experiences with naltrexone in 370 detoxified addicts.
    Thomas M; Kauders F; Harris M; Cooperstein J; Hough G; Resnick R
    NIDA Res Monogr; 1976 Sep; (9):88-92. PubMed ID: 794726
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Naltrexone in methadone maintenance patients electing to become "drug free".
    Haas N; Ling W; Holmes E; Blakis M; Litaker M
    NIDA Res Monogr; 1976 Sep; (9):70-3. PubMed ID: 794723
    [No Abstract]   [Full Text] [Related]  

  • 15. Clinical experience with naltrexone.
    O'Brien CP; Greenstein RA; Mintz J; Woody GE
    Am J Drug Alcohol Abuse; 1975; 2(3-4):365-77. PubMed ID: 1227298
    [No Abstract]   [Full Text] [Related]  

  • 16. Narcotic antagonists: naltrexone progress report: introduction.
    Renault PF
    NIDA Res Monogr; 1976 Sep; (9):1-3. PubMed ID: 794713
    [No Abstract]   [Full Text] [Related]  

  • 17. Short-term effects of naltrexone in 155 heroin ex-addicts.
    Volavka J; Resnick RB; Kestenbaum RS; Freedman AM
    Biol Psychiatry; 1976 Dec; 11(6):679-85. PubMed ID: 999987
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The theoretical basis of narcotic addiction treatment with narcotic antagonists.
    Wikler A
    NIDA Res Monogr; 1976 Sep; (9):119-22. PubMed ID: 1004530
    [No Abstract]   [Full Text] [Related]  

  • 19. The development of sustained action preparations of narcotic antagonists.
    Willette RE
    NIDA Res Monogr; 1978; (19):333-9. PubMed ID: 218109
    [No Abstract]   [Full Text] [Related]  

  • 20. Interim report on clinic intake and safety data collected from 17 NIDA-funded naltrexone studies.
    Bradford A; Hurley F; Golondzowski O; Dorrier C
    NIDA Res Monogr; 1976 Sep; (9):163-71. PubMed ID: 794717
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.